Cefbuperazone: Difference between revisions
Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 444604058 | IUPAC_name = (6''R'',7''S'')-7-([(2''R'',3''S'')-2-[(4-Ethyl-2,3-dioxopiperazine-1..." |
No edit summary |
||
Line 59: | Line 59: | ||
| molecular_weight = 627.65 g/mol | | molecular_weight = 627.65 g/mol | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Cefbuperazone''' ([[International Nonproprietary Name|INN]]) is a second-generation [[cephalosporin]] antibiotic.<ref>{{cite pmid|8904147}}</ref><ref>{{Patent|US|4754030|"Cefbuperazone crystalline triethylamine salt"}}</ref> | '''Cefbuperazone''' ([[International Nonproprietary Name|INN]]) is a second-generation [[cephalosporin]] antibiotic.<ref>{{cite pmid|8904147}}</ref><ref>{{Patent|US|4754030|"Cefbuperazone crystalline triethylamine salt"}}</ref> | ||
Line 65: | Line 69: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Cephalosporin antibiotics]] | [[Category:Cephalosporin antibiotics]] | ||
[[Category:Tetrazoles]] | [[Category:Tetrazoles]] | ||
[[Category:Piperazines]] | [[Category:Piperazines]] |
Latest revision as of 19:16, 8 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | IM, IV |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H29N9O9S2 |
Molar mass | 627.65 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Cefbuperazone |
Articles |
---|
Most recent articles on Cefbuperazone Most cited articles on Cefbuperazone |
Media |
Powerpoint slides on Cefbuperazone |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cefbuperazone at Clinical Trials.gov Trial results on Cefbuperazone Clinical Trials on Cefbuperazone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cefbuperazone NICE Guidance on Cefbuperazone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cefbuperazone Discussion groups on Cefbuperazone Patient Handouts on Cefbuperazone Directions to Hospitals Treating Cefbuperazone Risk calculators and risk factors for Cefbuperazone
|
Healthcare Provider Resources |
Causes & Risk Factors for Cefbuperazone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cefbuperazone (INN) is a second-generation cephalosporin antibiotic.[1][2]
References
- ↑ PMID 8904147 (PMID 8904147)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ Template:Patent
- Pages with script errors
- Pages with incomplete PMID references
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Cephalosporin antibiotics
- Tetrazoles
- Piperazines